Cargando…
Odanacatib, a New Drug for the Treatment of Osteoporosis: Review of the Results in Postmenopausal Women
Osteoclasts are specialized cells that initiate the process of bone resorption, which has two phases, dissolution of the mineral component and degradation of the organic matrix, in which cathepsin K plays a key role. Cathepsin K inhibitors, which block the activity of cathepsin on bone resorption la...
Autores principales: | Pérez-Castrillón, José Luis, Pinacho, Florentino, De Luis, Daniel, Lopez-Menendez, María, Dueñas Laita, Antonio |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951121/ https://www.ncbi.nlm.nih.gov/pubmed/20948576 http://dx.doi.org/10.4061/2010/401581 |
Ejemplares similares
-
Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial
por: Bone, H. G., et al.
Publicado: (2014) -
Erratum to: Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial
por: Bone, H. G., et al.
Publicado: (2015) -
Potential role of odanacatib in the treatment of osteoporosis
por: Ng, Kong Wah
Publicado: (2012) -
Relationship between Insulin Resistance (HOMA-IR), Trabecular Bone Score (TBS), and Three-Dimensional Dual-Energy X-ray Absorptiometry (3D-DXA) in Non-Diabetic Postmenopausal Women
por: Campillo-Sánchez, Francisco, et al.
Publicado: (2020) -
A multifunctional drug consisting of tetracycline conjugated with odanacatib for efficient periodontitis therapy
por: Li, Dengke, et al.
Publicado: (2022)